Diaryl ureas as cb1 antagonists

Details Diaryl ureas as cb1 antagonists Diaryl ureas as cb1 antagonists

A - Human Necessities

61

K

A61K 31/196 (2006.01) C07C 323/52 (2006.01) C07D 271/08 (2006.01)

Patent

CA 2575764

Compounds of Formula I are provided. In which the variables are as described herein. Such compounds may be used to modulate CB1 activity in vivo or in vitro, and are particularly useful in the treatment of conditions responsive to CB1 modulation in humans, domesticated companion animals and livestock animals, including appetite disorders, obesity and addictive disorders. Pharmaceutical compositions and methods for using them to treat such disorders are provided, as are methods for using such ligands for receptor localization studies and various in vitro assays.

L'invention porte sur des composés de formule (I) dont les variables sont données dans la description. Lesdits composés servent à moduler l'activité du CB1 in vivo ou in vitro, et sont particulièrement utiles pour traiter chez l'homme les états responsables de la modulation du CB1 chez l'homme et les amicaux domestiques, dont les troubles de l'appétit, l'obésité, et la toxicomanie. L'invention porte également sur des préparations pharmaceutiques les contenant, et sur des méthodes de traitement de ces troubles, et d'utilisation de ces ligands dans des études de localisation de récepteurs et différents bioessais in vitro.

Affiliated with

Also associated with

Rating

Diaryl ureas as cb1 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diaryl ureas as cb1 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diaryl ureas as cb1 antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1840780